Understanding the Brain

Souvenaid

From Cognopedia
Jump to: navigation, search

Souvenaid is a Medical food marketed for Alzheimer's disease by Danone (called Dannon in the US), consisting of a cocktail of nutrients including uridine monophosphate, choline, the omega-3 fatty acids EPA and DHA, phospholipids, B vitamins and antioxidants. As of January, 2010, Souvenaid is still being studied in clinical trials, and is not being sold commercially; details can be found at the product website.

The results of its first clinical trial were announced at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in July 2008[1][2]; the results were later published in the journal Alzheimer's & Dementia.[3]

The basic ideas behind this treatment were developed at the lab of Prof. Richard Wurtman of M.I.T.

Concerns have been expressed regarding possible conflicts of interests for this research.

Notes

  1. ICAD Press Release
  2. Alzheimer Research Forum news report
  3. http://www.alzheimersanddementia.org/article/PIIS1552526009023292/abstract

http://www.medscape.com/viewarticle/716581?src=mpnews&uac=77055EV&spon=26